2024-11-12 - Analysis Report
## Intuitive Surgical Inc (ISRG) Stock Analysis Report

This report provides a comprehensive analysis of Intuitive Surgical Inc (ISRG), a company that develops and markets minimally invasive surgical systems.

**1. Performance Analysis:**

* **ISRG's cumulative return:** 387.82%
* **S&P 500 (VOO) cumulative return:** 142.82%
* **ISRG outperformance:** 245.0 (84.28% relative to historical range)

**Performance Summary:**

| Year       | CAGR | MDD  | Alpha | Beta | Market Cap (B) |
|------------|------|-------|------|---------------|
| 2015-2017  | 108.3% | 16.7% | 78.1% | 0.8 | 43.33 |
| 2016-2018  | 162.5% | 23.9% | 137.8% | 1.2 | 56.86 |
| 2017-2019  | 176.3% | 23.9% | 133.2% | 1.4 | 70.19 |
| 2018-2020  | 118.0% | 40.4% | 78.9% | 1.2 | 97.13 |
| 2019-2021  | 131.3% | 40.4% | 41.5% | 1.2 | 127.98 |
| 2020-2022  | 33.3% | 45.8% | 15.6% | 1.2 | 94.51 |
| 2021-2023  | 26.5% | 45.8% | -2.3% | 1.4 | 120.16 |
| 2022-2024  | 49.0% | 45.1% | 23.8% | 1.3 | 186.74 |

**Analysis:**

* ISRG has consistently outperformed the S&P 500 over the past few years, with a significant outperformance of 245.0. 
* The high Alpha values indicate the company's outperformance compared to the market, showcasing its unique strengths and competitive advantages. 
* The Beta values remain relatively stable, indicating consistent market correlation, but with some periods of greater volatility.
* ISRG's market cap has consistently grown, reflecting the company's strong performance and market position.

**2. Recent Price Movement:**

* **Last closing price:** 536.45
* **Last market price:** 537.57
* **5-day moving average:** 519.77
* **20-day moving average:** 507.97
* **60-day moving average:** 492.26

**Analysis:**

* The recent price movement indicates a strong upward trend, with the current price trading above all moving averages.
* The stock is experiencing a positive momentum, suggesting a potential for further growth.
* The last market price indicates a slight uptick from the closing price, highlighting potential bullish activity. 

**3. Technical Indicators:**

* **RSI:** 65.04 
* **PPO:** 0.3
* **Recent (20 days) relative divergence change:** 10.49 (+)
* **Expected return:** 12.62%

**Analysis:**

* The RSI value of 65.04 suggests that the stock is in the overbought territory, but not excessively so. This indicates potential for a short-term pullback.
* The PPO value of 0.3 signals that the stock is experiencing a positive momentum but might be nearing a potential peak.
* The positive recent relative divergence change suggests a short-term bullish trend and confirms the upward price movement.
* The 12.62% expected return indicates a potentially attractive long-term investment opportunity, especially for a long-term buy-and-hold approach.

**4. Recent Earnings and Outlook:**

| Date        | EPS  | Revenue |
|-------------|------|---------|
| 2024-10-18 | 1.59 | 2.04 B$ |
| 2024-07-19 | 1.48 | 2.01 B$ |
| 2024-04-19 | 1.54 | 1.89 B$ |
| 2023-10-20 | 1.18 | 1.74 B$ |
| 2024-10-18 | 1.18 | 1.74 B$ |

**Analysis:**

* ISRG has consistently exceeded earnings estimates in recent quarters, indicating strong revenue growth and profitability.
* The company's revenue has been consistently growing, reflecting increasing demand for its minimally invasive surgical systems.
* The recent earnings report showed strong results, beating analysts' expectations for both EPS and revenue. This signifies continued positive growth and a favorable outlook for the company.

**5. Financial Information:**

**1) Revenue and Profitability:**

   | Quarter       | Revenue  | Profit Margin |
   |---------------|----------|----------------|
   | 2024-09-30  | $2.04B  | 67.41%        |
   | 2024-06-30  | $2.01B  | 68.30%        |
   | 2024-03-31  | $1.89B  | 65.87%        |
   | 2023-12-31  | $1.93B  | 66.24%        |
   | 2023-09-30  | $1.74B  | 66.94%        |

**2) Capital and Profitability:**

   | Quarter       | Equity   | ROE      |
   |---------------|----------|-----------|
   | 2024-09-30  | $15.58B  | 3.63%     |
   | 2024-06-30  | $14.71B  | 3.58%     |
   | 2024-03-31  | $13.96B  | 3.90%     |
   | 2023-12-31  | $13.31B  | 4.56%     |
   | 2023-09-30  | $12.54B  | 3.32%     |

**Analysis:**

* ISRG exhibits consistently high profit margins, indicating strong operational efficiency and competitive pricing power.
* The company's strong ROE signifies effective utilization of shareholder capital for profitable ventures. 
* The growing equity base reflects sound financial management and continued investment in operations.

**6. News and Recent Issues:**

* **Recent Earnings News:**
    * ISRG's recent earnings report (October 18, 2024) highlighted strong revenue growth and profitability. The company exceeded analysts' expectations, reaffirming its strong position in the minimally invasive surgical market. 
    * The company's CEO highlighted the continued demand for its da Vinci surgical systems and the expansion of its product portfolio as key drivers for future growth.

* **Market Outlook:**
    * The market outlook for ISRG remains positive, with analysts citing the company's strong market share, innovative product development, and expanding global reach as key drivers for future success.
    * The aging population and increasing demand for minimally invasive surgeries present a significant growth opportunity for the company.

* **Analyst Opinions:**
    * Most analysts hold a "Buy" or "Strong Buy" rating on ISRG, citing its strong financial performance, robust market position, and promising growth prospects.
    * Analyst consensus price targets are generally above the current trading price, suggesting further upside potential. 

**7. Comprehensive Analysis:**

Intuitive Surgical Inc (ISRG) presents a compelling investment opportunity for both short-term and long-term investors. The company exhibits strong financial performance, robust growth, and a leading market position in the rapidly growing minimally invasive surgical market. The company's innovative product development, expanding global reach, and favorable market outlook all contribute to its future growth potential. However, it is important to note that the stock is currently trading in the overbought territory, suggesting a potential for short-term pullbacks. Overall, ISRG remains a strong investment, especially for investors seeking a long-term exposure to the healthcare sector and the growing demand for minimally invasive surgical solutions.

**8. Conclusion:**

Based on its strong performance, favorable market outlook, and robust financial position, ISRG presents a compelling investment opportunity for investors seeking exposure to the healthcare sector. The company's innovation, market leadership, and consistent financial strength position it for continued growth in the future. However, it's important to monitor the stock's price movement and consider potential short-term fluctuations due to its recent price gains and overbought territory. 
